Saturday 17 October 2026
Export CRON’s income statement to Excel — free account
Cronos Group Inc.
CRON Healthcare Drug Manufacturers Specialty & Generic
Cronos Group Inc.’s revenue for fiscal 2025 (year ended December 2025) was $146.6 million, up 24.6% from fiscal 2024. In the quarter to June 2026, revenue grew 58.4%, EPS grew 190.0%, free cash flow grew 2,279.2% and total debt fell 4.71%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
3.22
0.02
+0.63%
Follow CRON
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
8 | 4 | 5 | 6 |
+8 more TTM periods Free account |
| 3.33% | (3.07%) | (3.72%) | 0.32% | ||
| 3.18% | (2.95%) | (3.55%) | 0.30% | ||
ROIC |
(0.34%) | (2.98%) | (3.34%) | (4.30%) | |
Return on Tangible Assets |
3.76% | (3.34%) | (4.03%) | 0.35% | |
Average Days of Receivables |
116.26 | 119.52 | 142.42 | 104.78 | |
Free Cash Flow per Share |
0.13 | 0.07 | 0.00 | (0.01) | |
Free Cash Flow |
49.44 | 26.19 | (0.19) | (5.74) | |
Capital Expenditures |
(10.61) | (12.67) | (26.06) | (27.49) | |
| Other line items | |||||
Cash ROIC |
2.58% | 1.35% | (0.01%) | (0.29%) | |
Accounts Receivable Turnover |
3.71 | 3.83 | 3.40 | 3.71 | |
Accounts Payable Turnover |
6.56 | 9.24 | 5.86 | 8.62 | |
Inventory Turnover |
2.04 | 2.19 | 2.10 | 1.57 | |
Average Days of Payables |
65.59 | 41.08 | 50.68 | 52.89 | |
Days of Inventory on Hand |
198.39 | 194.48 | 203.56 | 234.48 | |
Tax Rate |
0.31 | (0.28) | (0.28) | 0.04 | |
Research and Development Expense of Revenue |
2.99% | 3.18% | 3.04% | 3.09% | |
Selling, General and Administrative Expense of Revenue |
42.10% | 46.08% | 48.31% | 53.49% | |
Share Based Compensation of Revenue |
3.60% | 3.93% | 4.81% | 6.04% | |
Interest Coverage |
— | 0.75 | — | — | |
Operating CF/Net income |
1.60 | (1.13) | (0.62) | 6.10 | |
Depreciation/Fixed assets |
0.10 | 0.11 | 0.10 | 0.09 | |
Capex/Depreciation |
(0.74) | (0.84) | (1.83) | (2.10) | |
Revenue per Share |
0.48 | 0.42 | 0.38 | 0.35 | |
Operating CF per Share |
0.16 | 0.10 | 0.07 | 0.06 | |
Capex per Share |
(0.03) | (0.03) | (0.07) | (0.07) | |
Capex to Sales |
0.06 | 0.08 | 0.18 | 0.21 |
Columns are period end dates